您当前的位置：
首页 >
文章列表页 >
Compilation Instruction and Key Point Interpretation for Pharmacovigilance Guidelines for Clinical Application of Chinese Patent Medicines for Mucosal Administration
更新时间：2026-03-19

    • Compilation Instruction and Key Point Interpretation for Pharmacovigilance Guidelines for Clinical Application of Chinese Patent Medicines for Mucosal Administration

      增强出版
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 32, Issue 8, Pages: 260-266(2026)

    • DOI：10.13422/j.cnki.syfjx.20260494    

      CLC： R242;R283;R856.2

    • Received：29 July 2025，

      Online First：11 December 2025，

      Published：20 April 2026

    移动端阅览

  • LI Wenzhe,MA Rui,ZHAO Xiaoxiao,et al.Compilation Instruction and Key Point Interpretation for Pharmacovigilance Guidelines for Clinical Application of Chinese Patent Medicines for Mucosal Administration[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(08):260-266. DOI： 10.13422/j.cnki.syfjx.20260494.

  •  
  •  

0

Views

8

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Compilation Instruction for Pharmacovigilance Guidelines for Clinical Application of Traditional Chinese Medicine Injections
Interpretation of Evidence-to-decision Framework and Its Application in Pharmacovigilance Guidelines of Chinese Patent Medicines
Compilation Instruction for Pharmacovigilance Guideline for Clinical Application of Chinese Patent Medicine for External Use

Related Author

FU Changkuan
Wang Lianxin
ZOU Yihuai
LI Mingquan
LIN Yaming
SUN Weihong
WEI Xu
Chen Ming

Related Institution

General Hospital of Ningxia Medical University
Yunnan Provincial Hospital of Traditional Chinese Medicine
The Third Affiliated Hospital of Changchun University of Chinese Medicine
Wangjing Hospital， China Academy of Chinese Medical Sciences
Dongzhimen Hospital，Beijing University of Chinese Medicine
0